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Enzyme inhibitionThe inﬂuence of fullerenol on the activities of human erythrocyte membrane ATPases and the ﬂuidity of the
plasma membrane as well as the possibility of fullerenol incorporation into the plasma membrane were inves-
tigated. Fullerenol at concentrations up to 150 μg/mL induced statistically signiﬁcant decreases in the anisotro-
py of 1-anilino-8-naphthalene sulfonate (ANS) (14%), N,N,N-trimethyl-4-(6-phenyl-1,3,5,-hexatrien-1-yl)
phenylammonium p-toluenesulfonate (TMA-DPH) (7.5%) and 1,6-diphenyl-1,3,5-hexatriene (DPH) (9.5%)
after a 1-hour incubation at 37 °C. The effect disappeared for ANS and TMA-DPH, but not for DPH, after washing
out the fullerenol. Incubation of erythrocyte membranes with fullerenol led to decreases in the activities of Na+,
K+-ATPase (to 23% of the control value), Ca2+-ATPase (to 16% of control) andMg2+-ATPase (to 22% of control).
Washing out the fullerenol lessened the inhibition of the Na+,K+-ATPase (37% of control) and Ca2+-ATPase
(23.5% of control); however, it did not inﬂuence Mg2+-ATPase activity. Furthermore, fullerenol could associate
with erythrocyte plasma membranes.
Our results suggest that fullerenol associates primarily with the surface of the plasma membrane; however, it
can also migrate deeper inside the membrane. Moreover, fullerenol inﬂuences membrane ATPases so that it
may modulate ion transport across membranes.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
In recent years a great deal of attention has been paid to the unique
physicochemical properties of nanocompounds and their possible use
in biology and medicine [1–4]. A very promising group among these
is the fullerenes. Fullerenes are molecules built of rings, each consisting
of 5 to 6 carbon atoms, bound by coupled π bonds. Results from many
studies point to the great dependence of fullerenes' activity upon the
quality, quantity and geometry of substituents in fullerene derivatives.
Water-soluble fullerenes, such as hydroxylated C60 derivatives
(fullerenols), have become a major point of interest in biomedical
nanotechnology, thanks to their low toxicity compared to nano-C60
suspensions.
Sayes et al. [5] have investigated the toxicity of four fullerene deriv-
atives on human skin ﬁbroblasts and human liver cancer cells. They
have shown that the largest toxic effect was demonstrated by water
suspensions of C60. They demonstrated that cytotoxicity depends on
the C60 cage derivatization, and decreases along with increasing
water solubility of the specimen. Differentiation of the cytotoxic effectBiophysics, University of Lodz,
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ebowski),
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rights reserved.is, in their opinion, caused by different interactions of fullerene deriva-
tives with macromolecules in the plasma membrane.
A great deal of research has been done in order to explain the
higher toxicity of C60 compared to C60(OH)n. These studies concerned
the interactions of fullerenes with the lipid bilayer and the possibility
of fullerene crossing the plasma membranes. It was observed that
hydrophobic molecules of C60 were localized within the inner part
of the membrane, whereas hydrophilic C60(OH)n molecules were
adsorbed on the heads of membrane phospholipids [6]. Due to the
presence of hydroxyl groups on the surface of fullerenol molecules,
it is possible for them to take part in many interactions, e.g. creating
hydrogen bonds with biomolecules. Hydrogen bonds are relatively
weak interactions compared to covalent bonds; nevertheless, they
play an important role due to their frequent occurrence in biological
systems and their roles in biochemistry and cell maintenance [7,8].
The many hydroxyl groups on the surface of fullerenol molecules
make it possible for them to form hydrogen bonds between different
biomolecules. In effect, fullerenol can adsorb on the heads of mem-
brane phospholipids and interact with membrane proteins, thus
inﬂuencing their functions. Membrane proteins play crucial roles in
maintaining plasma membrane function. They are responsible for se-
lective transport, the shape and architecture of the cell, and signal
transduction [9].
Moreover, the high aqueous solubility and neutral pH of highly
hydroxylated fullerenes and their accessibility to further modiﬁcation
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in the cell, as well as potential anti-cancer agents to kill tumor cells
[10–12]. The hydroxyl groups increase hydrophilicity, which can be
useful for delivering sparingly water-soluble or hydrophobic cytotoxic
agents. Furthermore, fullerenol C60(OH)24 exhibits excellent cardio-
and hepatoprotective effects in rats treated with doxorubicin (DOX)
[13]. Fullerenols have the ability to quench various free radicals, behav-
ing as “free radical sponges”.
Membrane proteins with ATPase activity, which are responsible
for enabling asymmetric concentrations of cations across the mem-
brane at the expense of ATP hydrolysis, play a very important role in
cell functioning. Among the transport ATPases worth mentioning are
Na+/K+-ATPase, which transports Na+ outside and K+ ions inside
the cell [14] and Ca2+-ATPase, which is responsible for the transport
of Ca2+ to the extracellular space [15]. Both enzymes require Mg2+
ions for the active transport of cations [16].
Impaired Na+/K+-ATPase function can be linked to very severe
effects. It has been shown that a decrease in the activity of Na+,
K+-ATPasemay result in either apoptotic or “mixed” cell death. Deplet-
ing intracellular K+ triggers an increase in intracellular Ca2+, an event
perceived as a trigger for excitotoxicity leading to necrotic cell death
[17].
Bearing this in mind, it is reasonable to investigate the interactions
of fullerenols not only with the lipid bilayer of the plasma membrane,
but also with the proteins anchored to it. It is known, for example,
that the activity of ATPases can be inﬂuenced either by a direct inter-
action with other molecules or by changes in the ﬂuidity of the lipid
bilayer [18].
The aim of this work was to assess the inﬂuence of fullerenol
C60(OH)~30 on selected parameters of erythrocyte membranes. In
our work, the inﬂuence of fullerenol on the activity of human erythro-
cyte membrane ATPases and the ﬂuidity of the plasma membrane
were investigated for the ﬁrst time.
2. Materials and methods
2.1. Chemicals
Fullerene (99.5%) was purchased from SES Research. Bovine
serum albumin (BSA), phenylmethanesulfonyl ﬂuoride (PMSF),
tris(hydroxymethyl)aminomethane (Tris), ethylene glycol-bis(2-
aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA), adenosine 5′-
triphosphate disodium salt hydrate (ATP), ammoniumheptamolybdate
tetrahydrate, poly(vinyl alcohol) (PVA), trichloroacetic acid (TCA),
ouabain, 1-anilino-8-naphthalene sulfonate (ANS), 1,6-diphenyl-1,3,5-
hexatriene (DPH), N,N,N-trimethyl-4-(6-phenyl-1,3,5,-hexatrien-1-yl)
phenylammonium p-toluenesulfonate (TMA-DPH) were purchased
from Sigma-Aldrich. Sodium chloride, potassium chloride, calcium
chloride, magnesium chloride hexahydrate, potassium phosphate
monobasic, copper(II) sulfate(VI), sodium carbonate, sodium citrate
monohydrate, malachite green oxalate salt, ethylenediaminetetraacetic
acid disodium salt dihydrate (EDTA), Folin–Ciocalteau reagent, pyrene,
hydrochloric acid, sulfuric acid, methanol and tetrahydrofuran (THF)
were purchased from POCh (Poland).
Other chemicals were of the best quality commercially avail-
able. All solutions were made with water puriﬁed by the Milli-Q
system.
2.2. Synthesis of fullerenol
Polihydroxyfullerene (fullerenol) C60(OH)~30 was synthesized
according to the method of Wang et al. [19], which was modiﬁed to
increase the number of hydroxyl groups bound to C60. In our work
the reaction time between fullerene, sodium hydroxide and hydrogen
peroxide (NaOH, H2O2) was prolonged up to 25 min under stirring.
Next, the additional incubation in a water-bath at 60 °C was carriedout for 20 min. Moreover, the time of hydrolysis with deionized
water was prolonged from 10 min to 24 h. After precipitation of
fullerenol by methanol and resolubilization in deionized water, traces
of NaOH were removed by ion-exchange chromatography with
Amberlit MB-20.
The structure of the obtained hydroxyl derivative of fullerene C60
was conﬁrmed by IR spectrophotometry (NEXUS FT-IR spectrometer),
1H NMR (Varian Gemini 200 MHz), 13C NMR (Bruker Avance III
600 MHz) and mass spectroscopy MS-ESI (Varian 500MS).
2.3. Preparation of erythrocytes
Blood samples from healthy adult donors were provided by the
Regional Blood Bank in Lodz. Erythrocytes were separated from
blood plasma and leukocytes by centrifugation at 400 g for 8 min.
All procedures were done at 4 °C. The buffy coat was removed, eryth-
rocytes were washed with PBS (pH 7.4) and resuspended in the same
buffer to obtain a hematocrit of 2%.
2.4. Preparation of erythrocyte membranes
Erythrocyte membranes were prepared according to the method
of Dodge et al. [20] with some modiﬁcations. Hemolysis was carried
out at 4 °C with 20 volumes of 20 mM Tris–HCl buffer (pH 7.4)
containing 1 mM EDTA and 0.5 mM PMSF to inhibit proteases. The
membrane ghosts were washed successively with 20, 10 and 5 mM
ice-cold Tris–HCl buffer (pH 7.4) until the ghosts were free of residual
hemoglobin. Protein concentration in the membrane preparations
was determined by the method of Lowry et al. [21]. The erythrocyte
ghosts were kept frozen at −20 °C and used within a week from of
preparation.
2.5. Measurements of membrane ﬂuidity
Erythrocytes (hematocrit of 2%) in PBS were incubated with
C60(OH)~30 at concentrations of 50, 100 and 150 μg/mL at 37 °C for
1 h. Then the fullerenol was removed from some of the samples by
rinsing 3 times with PBS and centrifugation (400 g, 5 min). The eryth-
rocytes, with or without the washes to remove fullerenol, were then
diluted 50-times to a hematocrit of 0.04% with PBS. Solutions of
DPH or TMA-DPH in tetrahydrofuran and ANS in PBS were added to
the erythrocyte suspensions to ﬁnal concentrations of 2 μM, 2 μM,
or 20 μM, respectively. The ﬁnal concentration of THF in suspensions
with DPH or TMA-DPH was 0.1% and did not affect the results. The
samples were incubated at 37 °C for 15 min in the dark. Fluorescence
anisotropy was assessed at the following excitation and emission
wavelengths: 360 nm and 435 nm for DPH, 365 nm and 425 nm for
TMA-DPH, 370 nm and 480 nm for ANS [22].
Fluorescence anisotropy (r) was calculated automatically by soft-
ware provided with the instrument, according to r=(Ivv− IvhG)/
(Ivv+2IvhG), where Ivv and Ivh are the intensities of the vertically and
horizontally polarized components of theﬂuorescent light, respectively,
after excitation with vertically polarized light. G= Ihv/Ihh is a grating
correction factor for the optical system.
The widths of the excitation and emission monochromator slits
were set to 10 nm for all ﬂuorescent probes. During measurement,
samples were thermostated at 37 °C with a Peltier device and stirred
with a magnetic bar.
Measurement of ﬂuorescence anisotropy was performed on a Cary
Eclipse (Varian, Australia) ﬂuorescence spectrophotometer equipped
with an automated polarizer accessory.
2.6. Measurement of the amount of membrane-bound fullerenol
Suspensions of erythrocyte membranes with different concentra-
tions of membrane protein (0.5, 1.0, 1.5 mg/mL) were incubated with
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Fig. 1. Fluorescence anisotropy of ANS incorporated into the erythrocyte membranes in
the presence of fullerenol; (A) red bars — fullerenol was not washed out, (B) blue
bars— fullerenol was washed out. Asterisks are used to mark values that are statistically
different in comparison with control values (*pb0.05, **pb0.01, ***pb0.001).
243J. Grebowski et al. / Biochimica et Biophysica Acta 1828 (2013) 241–248fullerenol (50–150 μg/mL) at 37 °C for 1 h and then washed with Tris–
HCl buffer to remove unbound fullerenol. The membranes were then
dissolved in a 2%-solution of dodecyl sulfate (SDS). After a 10-minute
incubation at ambient temperature, UV–Vis absorption spectra were
taken and the absorbance at 348 nm was read against the absorbance
of dissolved membranes as a background.
The quantity of fullerenol bound to the erythrocyte membranes
was taken from a calibration curve made for fullerenol solutions
over a concentration range of 4–70 μg/mL in SDS solution.
2.7. Measurements of Na+,K+-ATPase, Ca2+-ATPase and Mg2+-ATPase
activity
ATPase activities were determined by measuring the differences in
the level of liberation of inorganic phosphate from ATP during a
1-hour incubation of the membrane preparations at 37 °C [23,24].
Suspensions of erythrocytemembranes atmembraneprotein concen-
trations of 1.2 mg/mL were incubated with fullerenol (50–150 μg/mL)
at 37 °C for 1 h. After this time, fullerenol was removed from half the
samples by washing with a Tris–HCl buffer.
Enzyme activities were determined inmedium containing: 100 mM
Tris–HCl buffer (pH 7.4), 85 mM NaCl, 10 mM MgCl2, 10 mM KCl,
0.1 mM EGTA and 1 mM ATP. Reaction was started by mixing the ATP
containing solution (100 μL) with the solution containing the erythro-
cyte membranes (50 μL) after incubation with fullerenol (with or
without rinses to remove fullerenol). Samples were incubated for 1 h
at 37 °C. The reaction was stopped by the addition of 200 μL of
ice-cold 0.6 M trichloracetic acid. Samples were centrifuged at 9200 g
for 5 min and the supernatant was used for the determination of the
amount of liberated inorganic phosphate. The activity of Na+/K+-
ATPase was determined from the difference in the formation of inor-
ganic phosphate in the absence or presence of 0.1 mM ouabain. The
activity of Ca2+-ATPase was determined from the difference in the
formation of inorganic phosphate in the presence or absence of
0.2 mM CaCl2. The level of ATPase in the absence of Ca2+ ions and the
presence of ouabainwas determined as the basalMg2+-ATPase activity,
and calculated from the difference in the formation of inorganic phos-
phate in the presence and absence of Mg2+ and K+ ions. The amount
of liberated inorganic phosphate was determined according to the
improved malachite green assay [25], adapted for use in 96-well plates.
Supernatant samples of 40 μL were placed in 96-well plates. Next,
160 μL of water was added, followed by the addition of 40 μL of mal-
achite green solution (0.9 mM malachite green oxalate in 0.35% PVA
solution). After a 10 minute incubation at room temperature, 40 μL
of ammonium heptamolybdate (14 mM in 3.15 M H2SO4) was
added. After 10 min of incubation, absorbance at 610 nm was read
using a Cary 50 UV–Vis spectrophotometer, equipped with a Cary
50 MPR plate reader (Varian Scientiﬁc Instruments).
Pi concentration was taken from a calibration curve made using
0–20 μM of KH2PO4 as a standard.
The enzyme activity was expressed in nmol Pi mgprot−1 h−1.
2.8. Statistical analysis
All experiments were run at least 5 times. Values were expressed
as the mean±standard deviation (SD) of at least ﬁve independent
experiments. Data were analyzed by one-way analysis of variance
(ANOVA), followed by Tukey's post-hoc test, all using the GraphPad
4.0 software.
3. Results
3.1. The inﬂuence of fullerenol on erythrocyte membrane ﬂuidity
Fluorescent probes were used to evaluate the ﬂuidity of erythro-
cyte membranes. ANS, TMA-DPH and DPH were applied, which areknown to reﬂect membrane ﬂuidity at the membrane surface, in the
hydrophilic layer, and in the hydrophobic core of the lipid bilayer,
respectively [22,24,26]. In this study, human erythrocytes were treat-
ed with fullerenol at different concentrations and its effects on the
membranes were evaluated by measuring ﬂuorescence anisotropy
(r).
Fullerenol at concentrations of 50–150 μg/mL induced a statisti-
cally signiﬁcant decrease in the anisotropy of ANS after a 1-hour
incubation at 37 °C (Fig. 1A). This observation reveals that the ﬂuidity
of the outer layer of the plasma membrane increased.
When fullerenol was removed from the erythrocyte suspension
after a 1-hour incubation, the ﬂuorescence anisotropy of ANS was
the same as for samples incubated without fullerenol (Fig. 1B).
It can be concluded that fullerenol did not attach strongly to the
membrane surface. Therefore, it did not inﬂuence the ﬂuidity of the
hydrophilic region of the erythrocyte membrane after its removal
from the suspension by washing with PBS.
The ﬂuorescence anisotropy of TMA-DPH decreased after a 1-hour
incubation with fullerenol at 100 or 150 μg/mL (Fig. 2A), whereas the
ﬂuorescence anisotropy of TMA-DPH did not change at 50 μg/mL of
fullerenol.
The removal of fullerenol from the erythrocyte suspension re-
duced the effect of its inﬂuence on the ﬂuorescence anisotropy of
TMA-DPH (Fig. 2B).
The obtained results show the lack of inﬂuence of fullerenol, at con-
centrations of 100–150 μg/mL, on the ﬂuidity of the outer monolayer of
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Fig. 2. Fluorescence anisotropy of TMA-DPH incorporated into the erythrocyte
membranes in the presence of fullerenol; (A) red bars — fullerenol was not washed
out, (B) blue bars — fullerenol was washed out. Asterisks are used to mark values
that are statistically different in comparison with control values (*pb0.01).
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washing with PBS.
The ﬂuorescence anisotropy of DPH decreased after a 1-hour incu-
bation with fullerenol at 100 μg/mL, and at 150 μg/mL was 90.5% of
control (Fig. 3A). This meant that the ﬂuidity of the hydrophobic
region of the erythrocyte membrane increased after fullerenol treat-
ment at higher concentrations. Fullerenol at 50 μg/mL did not
inﬂuence the ﬂuorescence anisotropy of DPH.
Washing with PBS did not inﬂuence the effect of fullerenol treat-
ment (Fig. 3B). The maintenance of the increase in the ﬂuidity of
the hydrophobic region of the plasma membrane even after three
washing steps conﬁrms the stable incorporation of fullerenol into
the hydrophobic inner region of the lipid bilayer of the erythrocyte
membrane.
3.2. The amount of fullerenol incorporated into erythrocyte membranes
In order to check if fullerenol molecules can associate with the
erythrocyte plasma membrane, an experiment was set up in which
membrane preparations with a speciﬁc protein concentration
(0.5, 1.0 or 1.5 mg/mL) were incubated for 1 h at 37 °C with
C60(OH)~30 (Fig. 4). It was observed that the amount of fullerenol
bound to the membrane increased proportionally to the fullerenol con-
centration in the sample. The amount of fullerenol incorporated into
the plasma membrane was 2.50 μgC60(OH)~30/mgMPr for 50 μg/mL
of C60(OH)~30 in samples in which the protein concentration was
1 mg/mL, whereas in samples in which the fullerenol concentrationwas 3-fold higher (150 μg/mL) the amount of fullerenol incorporated
was 6.76 μgC60(OH)~30/mgMPr (MPr-membrane protein).
3.3. The inﬂuence of fullerenol on erythrocyte membrane ATPases
Incubation of erythrocyte membranes with fullerenol for 1 h led
to a decrease in the Na+/K+-ATPase activity proportional to the
020
40
60
80
100
120
0 50 100 150
Pe
rc
en
ta
ge
 
o
f i
ni
tia
l A
TP
-
as
e 
ac
tiv
ity
Fullerenol concentration [µg/mL]
Na+/K+ ATPase activity
after fullerenol washing out
with fullerenol
*
*
0
20
40
60
80
100
120
0 50 100 150
Pe
rc
en
ta
ge
 
o
f i
n
iti
al
 A
TP
-a
se
ac
tiv
ity
Fullerenol concentration [µg/mL]
Ca2+ ATPase activity
*
*
*
with fullerenol
after fullerenol washing out
*
*
*
0
20
40
60
80
100
120
0 50 100 150
Pe
rc
en
ta
ge
 
o
f i
ni
tia
l A
TP
-
as
e 
ac
tiv
ity
Fullerenol concentration [µg/mL]
Mg2+ ATPase activity
*
*
*
after fullerenol washing out
*
*
*
*
*
*
#
#
#
#
with fullerenol
*
Fig. 5. Initial activities for Na+/K+-ATPase, Ca2+-ATPase and basal Mg2+ dependent
ATPase activity, expressed as nmol Pi/(mg protein×h), were: 143.3±6.6, 226.0±5.6
and 115.5±7.8, respectively. Results are expressed as the percentage of the initial
ATPase activity with standard deviation shown as error bars. Asterisks are used to
mark values statistically different in comparison with control (* pb0.001); hashes —
difference between samples containing fullerenol and after its removal by washing
with PBS (# pb0.05).
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K+-ATPase activity by 51% at 50 μg/mL of fullerenol and by 77% at
150 μg/mL of fullerenol. The decreases in the ATPase activity were
still observed when fullerenol was removed from the membrane sus-
pensions by washing three times with PBS. In this case, the inhibition
of the Na+/K+-ATPase activity was smaller, by about 10–14%, in
comparison with the samples containing fullerenol during the ATPase
activity assessment.
Analogous experiments were made for Mg2+‐ATPase and Ca2+
ATPase. ATPases were inhibited with increasing fullerenol concentra-
tion either in the presence of fullerenol or after its removal by wash-
ing with PBS.
The decrease in the activity of Ca2+-ATPase after removing
fullerenol was lower by about 7–8% compared with samples in
which fullerenol was present during the Ca2+-ATPase activity
assessment.
Mg2+‐ATPase activity was inhibited by fullerenol to the same ex-
tent for samples either with fullerenol present or absent during the
assessment.
4. Discussion
Numerical simulations performed with the use of molecular dy-
namics done by Qiao et al. [27] have shown that fullerenols are able
to penetrate the plasma membrane. Hydrophobic C60 particles easily
penetrate the lipid bilayer, as shown by both molecular modeling
[27] and experimental data [28,29]. Fullerenol particles, however,
because of the presence of many hydroxyl groups on their surface,
have a hydrophilic character, which makes their transport across
the lipid bilayer of the plasma membrane more difﬁcult. Qiao et al.
in 2007 [27] estimated the penetration time of C60(OH)20 through
DPPC as 9 orders of magnitude longer compared to that of C60.
In this work, ﬂuorescent probes ANS, DPH and TMA-DPH were
used to investigate the inﬂuence of fullerenol on the ﬂuidity of the
plasma membrane.
Fluidity was estimated on the basis of the anisotropy coefﬁcients
(r) of the probes, which were located in different regions of the
erythrocyte membrane. According to Shinitzky and Barenholz [30],
anisotropy is inversely proportional to the ﬂuidity of the membrane.
The results obtained in our work show that fullerenol increased
the ﬂuidity of the membrane at concentrations between 50 and
150 μg/mL. The largest decrease in the value of the anisotropy coefﬁ-
cient (r) was observed in the case of the ANS probe (Fig. 1) located on
the hydrophilic surface of phospholipid heads and, therefore, provid-
ing information about the organization of the membrane at its surface
(Fig. 6).
For TMA-DPH (used to monitor the ﬂuidity in the hydrophobic–
hydrophilic region of the membrane) (Fig. 2) and DPH (providing
information from the hydrophobic region between the two leaﬂets
of the membrane bilayer) (Fig. 3), signiﬁcant changes were observed
only at fullerenol concentrations above 100 μg/mL. Thus, it can be
assumed that fullerenol binds mostly to the surface of the membrane,
but can also migrate deeper inside the membrane. This is in agree-
ment with the data of Monticelli et al. [6], which revealed that hydro-
philic particles of C60(OH)20 adsorb more strongly to the membrane
phospholipid heads.
The removal of fullerenol from an erythrocyte suspension caused
increases in the anisotropy coefﬁcients (r) for ANS and TMA-DPH
back to the levels observed in control erythrocytes. This observation
indicates that the adsorption of fullerenol is probably due to the
formation of hydrogen bonds, and removing it from the incubation
medium leads to the dissociation of fullerenol molecules from the
membrane surface.
The removal of fullerenol from the incubation medium had no in-
ﬂuence on the ﬂuidity of the hydrophobic region (Fig. 3). Molecules
of fullerenol that penetrated the lipid bilayer of the plasma membrane
Fig. 7. Fullerenol interactions with Na+/K+-ATPase subunits spanning a lipid bilayer.
(A) Attachment of fullerenol to the outer layer of the lipid bilayer; (B) fullerenol interac-
tions with β subunits of Na+/K+-ATPase; (C) simultaneous fullerenol interactions with
an enzyme and a lipid bilayer; (D) incorporation of fullerenol into the hydrophobic,
inner region of the lipid bilayer of the plasma membrane.
ANS
DPH
TMA-DPH
Fig. 6. The location of the ﬂuorescent probes ANS, TMA-DPH, DPH and fullerenol in the
lipid bilayer.
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the ﬂuidity of the inner part of the lipid bilayer even after washing.
Moreover, these results conﬁrm that fullerenol could penetrate the
plasma membrane.
The possibility of fullerenol associating with erythrocyte mem-
branes was conﬁrmed in the next experiment, in which erythrocyte
ghosts were incubated with fullerenol for 1 h at 37 °C. The amount
of fullerenol associated with the membranes was relatively propor-
tional to its concentration in the incubation medium, and inversely
proportional to the concentration of the membrane proteins (Fig. 4).
This is probably connected to the fact that at higher concentrations
of membrane proteins, the higher viscosity of the suspension can
affect the diffusion of fullerenol inside the membrane.
Xiao et al. [31] suggested a possible mechanism for fullerene pen-
etration through membranes via association with proteins. This
model assumed that the transport of PVP-C60-fullerene across the
membrane was controlled by certain proteins: protein I (8 kDa;
present in the cell membrane) and protein II (53 kDa; present in
the membrane and cytosol). Penetration through the membrane
was possible only for conjugates of C60-protein II while PVP remained
outside the cell. Other authors suggested endocytosis as a mechanism
of fullerenol transport through the plasma membrane [32,33,
reviewed in Ref. 34]. The next step was to investigate the activities
of membrane ATPases under the inﬂuence of fullerenol. Signiﬁcant
decreases in Na+/K+-ATPase, Ca2+-ATPase and Mg2+-ATPase activi-
ties were observed after fullerenol treatment (Fig. 5). Data obtained
by other research groups suggested that fullerenol was able to inhibit
the activity of mitochondrial Mg2+-ATPase. In this way it disabled the
phosphorylation of ADP and the regeneration of ATP [35]. Not only
fullerenol, but also C60 aggregates, could promote changes in the
ATPase activity. Prylutska et al. [36] have shown that the lipophilicity
of C60 aggregates and their afﬁnity for the plasma membranes of thy-
mocytes were high enough to promote the transport of its particles
inside the membrane, even if C60 was in aggregates. In conclusion,
C60 could accumulate in the lipid bilayer and suppress the activity of
Ca2+-dependent, membrane associated ecto-ATPases.
Our results indicated that fullerenol might inhibit the activity of the
membrane ATPase system despite the presence of\OH groups on the
surface of the carbon cage, which gave it a hydrophilic character and, as
a result, limited the penetration of the bilayer by the nanoparticles.
Functional changes in Na+/K+-ATPase under the inﬂuence of
fullenerol could be associated with two effects. The ﬁrst is the interac-
tion of fullerenol molecules with subunits of the enzyme. The Na+/
K+-ATPase is a tetramer composed of two identical catalytic subunits
α and two glycosylated β subunits [37]. The latter are crucial for the
appropriate location of the enzyme in the membrane and for its proper
functioning, as they regulate the activity of the α subunits [38].
Molecules of fullerenol penetrating the membrane could presumablyinteract with β subunits and through changes in their structure inﬂu-
ence the action of the whole enzyme.
These postulates are supported by the results of Calvaresi and
Zerbetto in 2010 [39], who proved using computational methods
the possibility of blocking the catalytic subunits of ATPases via inter-
action with fullerenols. As models they used rat Na+/K+-ATPase
(1MO8 in PDB), which through ATP hydrolysis maintains an appro-
priate gradient of Na+ and K+ ions on both sides of the membrane,
and bovine mitochondrial F1-ATPase (1EFR), participating in oxida-
tive phosphorylation providing ATP synthesis. In both models the
interaction of C60 with the enzymes can be described as the inhibition
of the catalytic mechanism. Within Na+/K+-ATPase, C60 binds to the
very mobile α1 subunit region delimited by Gln396-Ala416 [40,41].
On the other hand, in F1-ATPase, C60 interacts with both the α and
β subunits [41], hindering the rotational movement necessary for
the functioning of the protein.
Another explanation for the attenuation of Na+/K+-ATPase activity
could be the inﬂuence of fullerenol molecules on the lipids of the
plasma membrane (Fig. 7) and, in consequence, changes in its ﬂuidity.
Such changes have an impact on the ATPase activity [18]. For example,
cholesterol is a compound playing a major role in the regulation of the
structure and dynamics of the lipid bilayer. It can moderate the activi-
ties of various membrane transporters such as Ca2+ channels, Na+/
K+-ATPase, Ca2+-ATPase andMg2+-ATPase in different cells, including
erythrocytes and endothelial cells [42].
Therefore, it is possible to conclude that the observed decrease in
ATPase activity is a consequence of changes in the microviscosity of
the erythrocyte membrane, caused by the incorporation of C60(OH)~30
into its interior.
Despite the reduced toxicity of fullerenol compared to nano-C60
suspensions [5], the interactions between fullerenol and membrane
ATPases may cause abnormalities in cell functioning. Improper
ATPase activity can lead to very serious events. In the case of Na+,
K+-ATPase, a decrease in activity results in apoptosis [17]. Inhibition
of Na+,K+-ATPase leads to ion imbalance and osmotic hemolysis in
erythrocytes [43].
Furthermore, impairing the function of Ca2+-ATPase also has very
serious consequences. An increase in the concentration of intracellular
calcium ions promotes an increase in proteolysis via Ca2+-dependent
proteases [44]. Inhibiting the function of other membrane ATPases
(not participating in ion transport), which are dependent on Mg2+
ions, can cause abnormal lipid distribution between the outer and
247J. Grebowski et al. / Biochimica et Biophysica Acta 1828 (2013) 241–248inner layer of the membrane, thus changing the discoidal shape of the
erythrocytes [45].
The concentrations of fullerenol used in our work were rather
high, up to 150 mg/L so the observed effects were explicitly pro-
nounced. Such high nanoparticle concentrations are hardly expected
in real applications. However, fullerenes including fullerenol could
accumulate in organisms, achieving higher concentrations compared
to the concentrations applied. Moreover, nanoparticles could be
released to the environment bymeans of waste disposal or accidentally
during or after use, increasing exposure to them [46,47].
Derivatives of fullerenes are prone to activate interactions with
protein molecules; however, the type of interaction is highly depen-
dent on the functional groups attached to the carbon “fullerene
cage” [48–51]. The fullerenol used in our work is rich in \OH groups
on its surface, and therefore can interact with the functional groups of
amino acids via hydrogen bonds.
Similar results were obtained by Ciolkowski et al. [24] during an in-
vestigation of the inﬂuence of PAMAM-OH dendrimers on the activities
of erythrocyte membrane ATPases. They demonstrated that hydrogen
bonds are responsible for the interaction between PAMAM-OH and
the cell surface. Fullerenol has a spherical shape, and the presence
of\OH groups on the surface of that molecule can have similar effects
on membrane proteins.
The obtained results suggest that fullerenol could be transported
by erythrocytes in the circulatory system. On the other hand, the irre-
versible inhibition of membrane ATPases by fullerenol points to the
toxicity of the nanoparticles in the examined system, leading to
ionic imbalance and the erythrocyte shape alterations. These poten-
tially harmful effects to cells may be useful if we take into account
that erythrocytes with altered shape are removed from circulation
and absorbed by the liver and the spleen. These biological effects
may be a useful/promising approach in targeted therapy of hepatocel-
lular and spleen cancer.
Since a decrease in the activity of transport ATPases may result in
the apoptosis of cancer cells, fullerenol could also be regarded as a
new candidate for cancer chemotherapy.
In conclusion, fullerenol induced decreases in the anisotropy of
plasma membranes as determined with ﬂuorescent labels ANS,
TMA-DPH and DPH after a 1-hour incubation at 37 °C. The effect
disappeared after washing out the fullerenol for ANS and TMA-DPH,
but not for DPH. Incubation of erythrocyte membranes with
fullerenol led to decreases in Na+,K+-ATPase, Ca2+-ATPase and
Mg2+-ATPase activities. Washing out the fullerenol reduced the inhi-
bition of Na+,K+-ATPase and Ca2+-ATPase activities; however, it did
not inﬂuence Mg2+-ATPase activity. Furthermore, our results show
that fullerenol can associate with erythrocyte plasma membranes.
Fullerenol associated mostly with the surface of the plasma mem-
brane; however, it could also migrate deeper inside the membrane.
The changes in the activities of ATPases caused by fullerenol could
be the result of its direct and/or indirect (via membrane ﬂuidity
changes) interaction with the enzymes. Moreover, fullerenol
inhibited membrane ATPases, so it could modulate ion homeostasis,
which regulates cell death. The obtained results could help elucidate
the molecular mechanism of C60(OH)~30 and other fullerenols and
their derivatives.Anita Krokosz and Jacek Grebowski contributed equally to this
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